No abstract available
Publication types
-
Consensus Development Conference
-
Review
MeSH terms
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / analysis*
-
Biopsy / methods
-
Breast Neoplasms / chemistry
-
Breast Neoplasms / diagnosis*
-
Breast Neoplasms / economics
-
Breast Neoplasms / pathology
-
Breast Neoplasms / radiotherapy
-
Breast Neoplasms / surgery
-
Breast Neoplasms / therapy*
-
Carcinoma, Intraductal, Noninfiltrating / diagnosis
-
Carcinoma, Intraductal, Noninfiltrating / therapy
-
Chemotherapy, Adjuvant
-
Female
-
Gene Expression Profiling*
-
Gene Expression Regulation, Neoplastic
-
Health Care Costs
-
Humans
-
Magnetic Resonance Imaging / methods
-
Mammaplasty
-
Mammography
-
Mass Screening / methods*
-
Mastectomy, Segmental*
-
Minimally Invasive Surgical Procedures
-
Palpation
-
Prognosis
-
Radiotherapy, Adjuvant / methods
-
Receptor, ErbB-2 / analysis
-
Risk Assessment
-
Sentinel Lymph Node Biopsy
-
Specimen Handling
-
Ultrasonography, Mammary
-
United States
Substances
-
Antineoplastic Agents, Hormonal
-
Biomarkers, Tumor
-
ERBB2 protein, human
-
Receptor, ErbB-2